Making treatment guideline recommendations in chronic kidney disease and type 2 diabetes more accessible to primary care providers in the United States
Related Posts
Rastogi A, Sarkar M, Kawai K, Munoz G, Simon L, Hwang M, Khalid M, Rhee C. The Impact of Renin-Angiotensin Aldosterone System Inhibitors in IgA[...]
Naim MAAZ, Thomas F, Streja E, Davis RL, Kalantar-Zadeh K, Sumida K, Kovesdy CP. Renal Outcomes of Triglyceride-Targeting Lipid-Lowering Therapies versus Statins in Patients with[...]
Noguchi K, Wong LL, Izutsu CH, Rhee CM, Lee LF. Disparities in Kidney Transplantation Access and Outcomes among Native Hawaiians and Pacific Islanders in the[...]